Adverse cardiovascular events during treatment with pioglitazone and rosiglitazone: population based cohort study

BMJ - Tập 339 Số aug18 2 - Trang b2942-b2942 - 2009
David N. Juurlink1,2,3,4,5, Tara Gomes5, Lorraine L. Lipscombe5,6, Peter C. Austin1,7,5, J. E Hux1,2,4,5, Muhammad Mamdani8,1,2,5
1Department of Health Policy, Management and Evaluation, University of Toronto
2Department of Medicine, University of Toronto
3Department of Pediatrics, University of Toronto
4Division of Clinical Pharmacology and Toxicology, Department of Medicine, Sunnybrook Health Sciences Centre, 2075 Bayview Avenue, Toronto, ON, Canada M4N 3M5
5Institute for Clinical Evaluative Sciences, Toronto
6Women’s College Hospital, Toronto
7Department of Public Health Sciences, University of Toronto
8Applied Health Research Centre, Li Ka Shing Knowledge Institute, St Michael's Hospital, Toronto

Tóm tắt

Từ khóa


Tài liệu tham khảo

Thông tin
Thông tin xuất bản

BMJ

Tập 339 Số aug18 2

b2942-b2942

Thông tin tác giả